Filing Details
- Accession Number:
- 0001735276-20-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-13 16:06:18
- Reporting Period:
- 2020-02-12
- Accepted Time:
- 2020-02-13 16:06:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226295 | A Phillip Sharp | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-12 | 15,000 | $15.82 | 250,633 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-12 | 15,000 | $9.14 | 265,633 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-12 | 30,000 | $130.00 | 235,633 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-02-12 | 15,000 | $0.00 | 15,000 | $9.14 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-02-12 | 15,000 | $0.00 | 15,000 | $15.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-12-08 | 2020-12-08 | No | 4 | M | Direct |
| 0 | 2011-06-02 | 2020-06-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 31,266 | Indirect | by Trust |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.
- Includes shares of ALNY common stock held in trusts for the benefit of the children of Dr. Sharp, of which the spouse of Dr. Sharp and children are the trustees.
Billionaire Hedge Funds
